The FDA announced on November 15, 2013, that Actavis Inc voluntarily recalled BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg due to failed dissolution specifications. The recall affects 139,944 bottles distributed nationwide and in Puerto Rico.
How to tell if you have it
- Brand: Actavis
- Product: BuPROPion Hydrochloride XL 150mg Tablets
- NDC 0591-3331-30 (30 count bottle)
- NDC 0591-3331-19 (90 count bottle)
- NDC 0591-3331-05 (500 count bottle)
- Lots: 524099M, 524100A, 521687A
- Manufacturer: Watson Laboratories, Inc. Corona, CA
The hazard
The products failed stability testing for dissolution tests at the 18-month mark. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Actavis Inc has had 13 other recalls on record since March 22, 2013. Other recent recalls of similar products include Inventia Chlorthalidone Recall (September 3, 2026) and Teva Metoprolol Succinate Extended-Release Tablets Recall (January 29, 2026).